Scenic Biotech

Scenic Biotech

Private
AmsterdamHealthcare & Life Scienceshttps://scenicbiotech.com

Last Round

Series A

Mar 10, 2022

Total Funding Raised

$41.81M

Momentum Score

25 /100

Company Overview

Scenic Biotech is a biotechnology company that is advancing modifier therapy to treat genetic disorders.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Platform-as-a-Service, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

genetic modifiersmodifier therapydrug target discoveryCell-Seq platformfunctional genomicsdrug discovery platformtarget identificationsmall molecule therapeuticsrare genetic disordersbiopharma partnershipstechbio platformtarget validationimmuno-oncologyneurodegenerative diseasesclinical-stage biotechGalactosemia

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Scenic Biotech Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Scenic Biotech Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMar 10, 2022
GrantJun 23, 2020
Series AJun 5, 2017

Scenic Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 7, 2026

    Partnered with Ono Pharmaceutical for novel therapeutic target discovery.

  • Oct 27, 2025

    Partnered with Secarna Pharmaceuticals to develop novel therapies for genetic diseases.

Scenic Biotech Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Scenic Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Scenic Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersAmsterdam
Employee Range39
Year Founded2017
Last FundingMar 10, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.